Lycopene Following Aneurysmal Subarachnoid Haemorrhage

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

Also called NCT00905931

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 124 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT00905931
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT00905931. Randomized; quadruple masking; primary purpose prevention. Start 2010-09 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lycopene Following Aneurysmal Subarachnoid Haemorrhage
Acronym
LASH
Condition
Subarachnoid Hemorrhage
Condition
Aneurysm
Intervention (Drug)
Lycopene
Intervention (Drug)
placebo
Lead sponsor
University of Cambridge (class: other)
Collaborator
Cambridge Theranostics Ltd (class: industry)

Record details

Record id
cardio:ct-nct00905931
Content hash
aa21708979a2a6d686a6be1320734b51010e346f8e565e7381b5715fdd8ba73b